The 47 most sponsor-active Biotechnology newsletters, ranked by our Newsletter Leader Score.
Biotech and biopharma business-news briefings focused on science, people, financing, deals, regulation and drug development. The publication serves executives, investors and other senior life-sciences professionals.
A weekday biotech and pharma news newsletter covering clinical readouts, FDA decisions, gene therapy, drug pricing, financing, M&A and research partnerships. It is designed for pharmaceutical and biotechnology industry decision-makers.
A skimmable daily email covering the most important biotech and pharmaceutical news, including clinical trials, FDA decisions, financings, M&A and company launches. It is aimed at biotech and pharma professionals who want a concise industry…
A specialist biotech and life-sciences newsletter focused on AI in drug discovery, digital pathology, translational R&D, laboratory technology, and the intersection of software and biology. BiopharmaTrend markets newsletter sponsorships and…
A high-volume biotech trade publication covering clinical development, research, financing, M&A, regulatory policy, and company strategy. Its newsletter and broader Fierce Life Sciences network are heavily commercialized through sponsored c…
A weekly global biotech newsletter with a strong European focus, covering emerging companies, scientific technologies, funding rounds, industry trends, deals, and therapeutic areas. Labiotech reports a subscriber base of more than 20,000 ph…
A weekday life-sciences intelligence newsletter covering biotech breakthroughs, clinical trials, FDA activity, financing, M&A, medtech, diagnostics, and healthcare innovation. The publication sells prominent above-the-fold newsletter sponso…
A recurring biotech community newsletter and email-briefing program featuring regional and global biotechnology news, jobs, events, and company updates across Biotech Networks hubs.
A short daily biotech briefing covering financings, IPOs, M&A, clinical trials, policy, and notable scientific developments. It is designed as a five-minute, high-signal update for biotech professionals.
Daily weekday newsletters covering biotech and life-science activity across eight major U.S. clusters, including financings, clinical milestones, partnerships, hires, events, and regional ecosystem news. The newsletters are marketed to biot…
A weekly, informal biotech and life-science newsletter mixing industry news, company updates, jobs, directory developments, and humorous commentary for biotechnology professionals.
Weekly biotechnology coverage spanning scientific papers, funding rounds, emerging technologies, companies, and researchers. BioByte is the flagship newsletter of Decoding Bio, a community-oriented biotech media and events platform.
Weekly analysis of biotech and biopharma news, clinical-trial readouts, FDA decisions, M&A, public markets, and the science behind industry headlines.
A weekly LinkedIn-based newsletter covering AI in drug discovery, competitive dynamics, biotech platforms, therapeutic innovation, and technology-driven changes in life sciences.
A twice-weekly biotech and pharma briefing summarizing M&A, clinical breakthroughs, regulatory developments, funding, drug-discovery platforms, and industry strategy in a concise format. It targets scientists, founders, investors, operators…
STAT's weekday biotech newsletter covering the science, politics, money, clinical readouts, FDA decisions, deals, and major company developments shaping biotechnology. Issues are written by STAT's biotech reporting team rather than one cons…
A targeted life-science research newsletter program covering genetics, genomics, molecular biology, cell biology, microbiology, CRISPR, gene therapy, proteomics, and related biotechnology fields. Sponsors can purchase topic-specific placeme…
An independent weekly bulletin covering the British biotech and venture-capital ecosystem, including funding, scientific breakthroughs, pharmaceutical strategy, senior appointments, and life-science infrastructure. The newsletter is aimed a…
A weekly bioprocessing newsletter covering biologics manufacturing, capacity expansion, M&A, technology investment, regulation, and global market developments.
A practical bioscience newsletter delivering quick-read laboratory protocols, troubleshooting guidance, technical explainers, career advice, and research tools to working scientists.
Independent, subscription-supported biotech reporting and analysis covering drug development, diagnostics, genomics, regulatory issues, business strategy, and industry leaders. The publication explicitly operates without advertising and mon…
Biotech investing newsletter focused on clinical catalysts, regulatory events, drug-development strategy, portfolio tracking, and risk-adjusted analysis for public biotechnology companies.
Weekly, opinionated intelligence on how artificial intelligence is changing pharmaceutical research, biotech operations, drug discovery, scientific software, and regulated workflows.
A recurring life-science methods and biotechnology newsletter covering laboratory techniques, instrumentation, molecular biology, sequencing, imaging, and research tools. BioTechniques has documented newsletter advertising and sponsorship i…
A monthly biotech investing newsletter that breaks down drug-development science, clinical readouts, therapeutic areas, and company catalysts with an investment-oriented perspective.
A monthly Singapore-focused biotech newsletter covering local biomedical research, translational science, biotechnology events, ecosystem opportunities, and emerging life-sciences innovations.
Weekly synthetic-biology and biotechnology news covering biological engineering, biomanufacturing, therapeutics, food, materials, climate, startups, investors, and industry leaders. The publication is integrated with SynBioBeta's conference…
Independent essays on data, companies, scientific ideas, and investment themes at the frontier of biology. The newsletter combines biotech analysis with perspectives on company-building, AI, therapeutics, and the future of life sciences.
A high-content biotech investing newsletter covering clinical data, drug mechanisms, catalysts, regulatory paths, and valuation for small- and mid-cap biotechnology companies.
A high-frequency biotech and life-sciences newsletter covering genetic engineering, drug discovery, bioprocessing, translational medicine, and emerging biotechnology.
A daily Asia-Pacific life-sciences newsletter covering biotechnology, pharma, medtech, clinical trials, funding, regulation, manufacturing, and startup activity.
BIO's biotech publication and newsletter covering biotechnology policy, innovation, health, research, investment, and industry events. The newsletter is positioned as a concise briefing for the global biotech ecosystem and has a formal spon…
A biotech venture newsletter for LPs, founders, and investors, combining capital-flow analysis, fund strategy, company financing, clinical catalysts, and weekly biotech news.
A newsletter on preclinical biotech and the commercialization of early-stage biomedical science. It covers translational research, preclinical startups, funding, licensing, deals, and the scientific evidence needed to move programs toward f…
A science-first biotech newsletter and research service analyzing clinical-stage companies through molecular mechanisms, clinical data, intellectual property, competitive positioning, and catalysts.
A daily biotechnology newsletter focused on biotech policy, regulation, advocacy, public affairs and industry developments. It is primarily read by biotechnology executives, policy professionals, researchers and stakeholders following the g…
An independent, reader-supported newsletter focused on small- and mid-cap biotechnology stocks, clinical catalysts, company-specific research, and investment theses. The publication is aimed primarily at biotech investors and public-markets…
A biotech industry newsletter covering biotechnology policy, regulation, innovation, investment, public health, and the political issues affecting life-science companies.
A high-frequency biotech newsletter covering public and private market updates, company building, financing, exits, regulatory developments, clinical programs, and emerging science. The publication operates under a pseudonymous brand and pu…
An independent biotech intelligence publication covering approvals, financings, platform technologies, healthcare investment, AI in drug discovery, medtech, and regulatory policy.
ARM's weekly newsletter covering cell and gene therapy business deals, manufacturing developments, clinical updates, policy, and sector intelligence. ARM explicitly sells digital advertising in the newsletter and reports an audience of more…
A high-frequency biotech investing newsletter tracking acquisition candidates, IPOs, reverse mergers, deal activity, catalysts, and pharmaceutical-company strategy.
An independent weekday briefing covering pharmaceutical, biotechnology, healthcare, regulatory, and market developments in a short daily format.
A high-density pharma and biotech intelligence briefing synthesizing regulatory decisions, financings, clinical developments, gene and cell therapy news, and AI-enabled drug discovery.
A paid newsletter focused on biotechnology investment research, clinical catalysts, public-company analysis, and long-term biotech portfolio construction. The publication explicitly states that it accepts no advertising and is supported by …
A practical newsletter and educational publication for modern biologists, covering CRISPR, molecular biology, sequencing, bioinformatics, R, Python, lab software, and tool reviews. Its sponsor page offers newsletter placements, sponsored de…
A paid-and-free Substack focused on biotechnology and artificial intelligence from a working R&D scientist. It covers open biology, AI-enabled drug discovery, computational biology, lab infrastructure, scientific software, and the commercia…
These are real sponsors backing the communities on this list — discovered by Sponsor Scout's daily AI agent. Sign up free to see who's actively sponsoring right now, find the decision-makers, and reach out.
Property owners can submit evidence for Sponsor Scout review. Acceptance into Sponsor Scout does not guarantee placement in the public Top 25; rankings remain evidence-based and editorially independent.
Sign up to submit → Already have an account? Sign inEvery newsletter is scored 0–100 by Sponsor Scout as we search the open web daily. The score rewards newsletters that reach real audiences and consistently attract sponsors. These findings are updated regularly.
Sponsor Scout hunts the web every day for companies sponsoring startup & tech events, finds the right decision-maker, and drafts the outreach for you. Start free — 20 sponsors and 4 scout runs every month, no credit card.
One short email each weekday: a real story about a real company sponsoring the startup ecosystem, plus the day's freshest finds.